Identifying High Cholesterol in the Ambulance Setting: a Mixed-Methods Cohort Study to Tackle Health Inequality
Source : https://pubmed.ncbi.nlm.nih.gov/38291949/
Undiagnosed hyperlipidaemia exists in patients using the ambulance service, irrespective of SES. Individual and healthcare system factors prevent engagement in cholesterol lowering behaviours.
Socioeconomic status was not associated with hyperlipidemia or likelihood of seeking further management; rather, it was dictated by competing comorbidities, poor health literacy, and digital divides.
Cardiometabolic and Renal Phenotypes and Transitions in the United States Population
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615595/
Cardiovascular and renal conditions have both shared and distinct determinants. In this study, we applied unsupervised clustering to multiple rounds of the National Health and Nutrition Examination Survey from 1988...
The cardiometabolic and renal traits of the US population have shifted from phenotypes with high blood pressure and cholesterol toward poor kidney function, hyperglycemia, and severe obesity.
Ceramides Improve Cardiovascular Risk Prediction Beyond Low-Density Lipoprotein Cholesterol
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10826640/
Low-density lipoprotein cholesterol (LDL-C) is the best documented cardiovascular risk predictor and at the same time serves as a target for lipid-lowering therapy. However, the power of LDL-C to predict...
Ceramides- and phosphatidylcholine-based predictors rather than LDL-C may be used for a more accurate cardiovascular risk prediction in patients at high risk.
Presence of familial hypercholesterolemia variants was associated with a 2-fold higher risk of coronary heart disease, even when LDL-C levels were moderately elevated.
Effect of Supplementation With Probiotics or Synbiotics on Cardiovascular Risk Factors in Patients With Metabolic Syndrome: a Systematic Review and Meta-Analysis of Randomized Clinical Trials
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10801034/
The effectiveness of probiotics or synbiotics in adults with metabolic syndromes (MetS) remains controversial, this meta-analysis will further analyze the effects of probiotics or synbiotics on cardiovascular factors in adults...
Supplementation with probiotics or synbiotics can reduce BMI, LDL-C, and fasting blood glucose in patients with metabolic syndrome, but the findings did not demonstrate a favorable effect on reducing systolic blood pressure.
